loadpatents
Patent applications and USPTO patent grants for Rosen; Steven D..The latest application filed is for "inhibition of leukocyte adhesion".
Patent | Date |
---|---|
Inhibition Of Leukocyte Adhesion App 20120328632 - Lasky; Laurence A. ;   et al. | 2012-12-27 |
Sulfatases and methods of use thereof Grant 8,216,580 - Nawroth , et al. July 10, 2 | 2012-07-10 |
Inhibition of leukocyte adhesion App 20080241143 - Lasky; Laurence A. ;   et al. | 2008-10-02 |
Lymphocyte homing receptors App 20060229435 - Lasky; Laurence A. ;   et al. | 2006-10-12 |
Glycosyl sulfotransferase-3 Grant 6,967,093 - Bistrup , et al. November 22, 2 | 2005-11-22 |
Methods of treating traumatic spinal cord injury App 20050255098 - Rosen, Steven D. ;   et al. | 2005-11-17 |
Selectin ligands App 20050222011 - Rosen, Steven D. ;   et al. | 2005-10-06 |
Hec-g1cnac6st Grant 6,933,142 - Bistrup , et al. August 23, 2 | 2005-08-23 |
Glycosyl sulfotransferases GST-4.alpha., GST-4.beta., and GST-6 Grant 6,852,518 - Rosen , et al. February 8, 2 | 2005-02-08 |
Methods of inhibition using glycosyl sulfotransferase-3 Grant 6,844,175 - Bistrup , et al. January 18, 2 | 2005-01-18 |
Novel glycosyl sulfotransferases GST-4alpha, GST-4beta, & GST-6 App 20040185546 - Rosen, Steven D. ;   et al. | 2004-09-23 |
Inhibition of leukocyte adhesion App 20040141966 - Lasky, Laurence A. ;   et al. | 2004-07-22 |
Glycosyl sulfotransferase-3 App 20020164748 - Bistrup, Annette ;   et al. | 2002-11-07 |
Endoglycan: a novel protein having selectin ligand and chemokine presentation activity Grant 6,380,371 - Sassetti , et al. April 30, 2 | 2002-04-30 |
Novel selection ligands App 20020025923 - Rosen, Steven D. ;   et al. | 2002-02-28 |
Glycosyl sulfotransferase-3 App 20010051370 - Bistrup, Annette ;   et al. | 2001-12-13 |
Sulfated disaccharide inhibitors of selectins, methods for synthesis and therapeutic use Grant 5,977,080 - Rosen , et al. November 2, 1 | 1999-11-02 |
Assays for inhibitors of leukocyte adhesion Grant 5,972,625 - Rosen , et al. October 26, 1 | 1999-10-26 |
Soluble lymphocyte homing receptors Grant 5,840,844 - Lasky , et al. November 24, 1 | 1998-11-24 |
Treating inflammation via the administration of specific sulfatase enzymes and/or sulfation inhibitor Grant 5,695,752 - Rosen , et al. December 9, 1 | 1997-12-09 |
Sulfate ligands for L-selectins and methods of preventing sulfate addition Grant 5,580,862 - Rosen , et al. December 3, 1 | 1996-12-03 |
Selectin ligands Grant 5,484,891 - Lasky , et al. January 16, 1 | 1996-01-16 |
DNA sequence encoding a selectin ligand Grant 5,304,640 - Lasky , et al. April 19, 1 | 1994-04-19 |
Lymphocyte homing receptors Grant 5,216,131 - Lasky , et al. June 1, 1 | 1993-06-01 |
DNA sequence encoding a functional domain of a lymphocyte homing receptor Grant 5,098,833 - Lasky , et al. March 24, 1 | 1992-03-24 |
NCAGE Code | 49XZ8 | ROSEN STEVEN D |
CAGE Code | 49XZ8 | ROSEN, STEVEN D |
uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.
While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.
All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.